POST HOC SUBGROUP ANALYSIS OF ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: 5 YEAR FOLLOW-UP DATA

被引：0
|
作者：
Lehner, F. [1 ]
Budde, K. [1 ]
Suwelack, B. [1 ]
Arns, W. [1 ]
Wuethrich, R. P. [2 ]
Reinke, P. [1 ]
Muehlfeld, A. [1 ]
Eisenberger, U. [1 ]
Stahl, R. [1 ]
Porstner, M. [3 ]
Heller, K. [1 ]
Wolters, H. H. [1 ]
Witzke, O. [1 ]
Hauser, I. A. [1 ]
Sommerer, C. [1 ]
机构：
[1] Zeus Study Grp, Munich, Germany
[2] Zeus Study Grp, Geneva, Switzerland
[3] Novartis Pharmaceut, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P171
引用
收藏
页码：58 / 58
页数：1
相关论文
共 38 条
  • [1] Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data
    Lehner, F.
    Budde, K.
    Wuethrich, R.
    Reinke, P.
    Arns, W.
    Muehlfeld, A.
    Eisenberger, U.
    Stahl, R.
    Heller, K.
    Witzke, O.
    Suwelack, B.
    Wolters, H.
    Hauser, I.
    Porstner, M.
    Sommerer, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [2] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: A POST HOC SUBGROUP ANALYSIS OF ZEUS
    Lehner, F.
    Budde, K.
    Wuethrich, R. P.
    Witzke, O.
    Zeier, M.
    Hauser, I. A.
    Wolters, H. H.
    Suwelack, B.
    Heller, K.
    Reinke, P.
    Arns, W.
    Stahl, R.
    Muehlfeld, A.
    Eisenberger, U.
    Baeumer, D.
    Porstner, M.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 24 - 24
  • [3] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    [J]. TRANSPLANTATION, 2014, 98 : 613 - 613
  • [4] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 613 - 613
  • [5] POST HOC SUBGROUP ANALYSIS FROM ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuethrich, R. P.
    Pressmar, K.
    Porstner, M.
    May, C.
    Paulus, E. -M.
    Muehlfeld, A.
    Wolters, H. H.
    Witzke, O.
    Stahl, R. O.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 8 - 8
  • [6] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CNI TO EVEROLIMUS-BASED REGIMEN: 5 YEAR DATA POST HOC ANALYSIS FROM THE ZEUS STUDY
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Budde, K.
    Wuethrich, R.
    Reinke, P.
    Muehlfeld, A.
    Eisenberger, U.
    Stahl, R.
    Heller, K.
    Suwelack, B.
    Wolters, H.
    Hauser, I.
    Porstner, M.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 242 - 243
  • [7] Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study
    Lehner, Frank
    Budde, Klemens
    Zeier, Martin
    Wuethrich, Rudolf P.
    Reinke, Petra
    Eisenberger, Ute
    Muehlfeld, Anja
    Arns, Wolfgang
    Stahl, Rolf
    Heller, Katharina
    Witzke, Oliver
    Wolters, Heiner H.
    Suwelack, Barbara
    Klehr, Hans Ulrich
    Stangl, Manfred
    Hauser, Ingeborg A.
    Nadalin, Silvio
    Porstner, Martina
    May, Christoph
    Paulus, Eva-Maria
    Sommerer, Claudia
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 (11) : 1192 - 1204
  • [8] RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 2 YEAR FOLLOW-UP DATA OF THE APOLLO TRIAL
    Sommerer, Claudia
    Rath, Thomas
    Budde, Klemens
    Haller, Hermann
    Arns, Wolfgang
    Scheidl, Stefan
    Vogel, Eva-Maria
    Witzke, Oliver
    Reinke, Petra
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 180
  • [9] OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 5 YEAR DATA OF THE APOLLO TRIAL
    Rath, T.
    Sommerer, C.
    Suwelack, B.
    Arns, W.
    Haller, H.
    Reinke, P.
    Budde, K.
    Baeumer, D.
    Porstner, M.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 50 - 50
  • [10] 5-YEAR FOLLOW-UP RESULTS OF THE HERAKLES STUDY: SUPERIOR RENAL FUNCTION AFTER EARLY CONVERSION TO AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN
    Lehner, F.
    Guba, M.
    Sommerer, C.
    Stahl, R.
    Vogt, B.
    Hauser, I.
    Reinke, P.
    Jacobi, J.
    Weithofer, P.
    Rath, T.
    Junge, M.
    Arns, W.
    Budde, K.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 35 - 35
1234